CompletedNot Applicable

Effectiveness of Hydroxyapatite Reinforced Chitosan Hydrogel in Modulation of Osseointegration

Egypt20 participantsStarted 2023-03-28

Plain-language summary

Dental implant treatments have now become indispensable in clinical dental practice. The survival rate exceeds 90%; Modern oral implantology uses different devices, in terms of size, shape, length, thickness and composition, from pure titanium to titanium-aluminum-vanadium alloys, due to their biocompatibility and high corrosion resistance

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy patients (class I category according to American society of anesthesiologists ) * Over 20 years and under 50 years of age * Either gender * Patients seeking extraction and placement of immediate dental implant for mandibular teeth. Exclusion Criteria: * Any acute infection in surgical sites * Long term non-steroidal anti-inflammatory drug therapy * Periodontal disease with bone loss * Known allergy to any of the materials used in the study * Patients with severely atrophic ridges requiring a staged grafting procedure * Patients with significant medical condition * Alcoholic individuals * Patients on drugs that affect the central nervous systems * Patients who reported the use of drugs that might interfere with pain sensitivity * Pregnant and lactating

What they're measuring

Clinical assessment of osseintegration

Timeframe: 6 months

Trial details

NCT IDNCT06758440

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-20

View on ClinicalTrials.gov More Osseointegration Failure of Dental Implant trials